Literature DB >> 11846615

DNA methylation analysis by MethyLight technology.

B N Trinh1, T I Long, P W Laird.   

Abstract

MethyLight is a sensitive, fluorescence-based real-time PCR technique that is capable of quantitating DNA methylation at a particular locus by using DNA oligonucleotides that anneal differentially to bisulfite-converted DNA according to the methylation status in the original genomic DNA. The use of three oligonucleotides (forward and reverse primers, and interpositioned probe) in MethyLight, any one or more of which can be used for methylation discrimination, allows for a high degree of specificity, sensitivity, and flexibility in methylation detection. Copyright 2001 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11846615     DOI: 10.1006/meth.2001.1268

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  44 in total

Review 1.  Novel agents for chemoprevention, screening methods, and sampling issues.

Authors:  Mary Jo Fackler; Ella Evron; Seema A Khan; Saraswati Sukumar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-01       Impact factor: 2.673

2.  Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells.

Authors:  Ben Youngblood; Kenneth J Oestreich; Sang-Jun Ha; Jaikumar Duraiswamy; Rama S Akondy; Erin E West; Zhengyu Wei; Peiyuan Lu; James W Austin; James L Riley; Jeremy M Boss; Rafi Ahmed
Journal:  Immunity       Date:  2011-09-23       Impact factor: 31.745

3.  Epigenetics DNA methylation in the core ataxin-2 gene promoter: novel physiological and pathological implications.

Authors:  José Miguel Laffita-Mesa; Peter O Bauer; Vivian Kourí; Leodani Peña Serrano; Jane Roskams; Dennis Almaguer Gotay; Julio Cesar Montes Brown; Pedro Ariel Martínez Rodríguez; Yanetza González-Zaldívar; Luís Almaguer Mederos; Dany Cuello-Almarales; Jorge Aguiar Santiago
Journal:  Hum Genet       Date:  2011-10-30       Impact factor: 4.132

4.  Genome-wide DNA methylation assessment of 'BRCA1-like' early-onset breast cancer: Data from the Australian Breast Cancer Family Registry.

Authors:  Cameron M Scott; Ee Ming Wong; JiHoon Eric Joo; Pierre-Antoine Dugué; Chol-Hee Jung; Neil O'Callaghan; James Dowty; Graham G Giles; John L Hopper; Melissa C Southey
Journal:  Exp Mol Pathol       Date:  2018-11-10       Impact factor: 3.362

5.  Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening.

Authors:  Dao-Rong Wang; Dong Tang
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

6.  Specificity of methylation assays in cancer research: a guideline for designing primers and probes.

Authors:  Zeinab Barekati; Ramin Radpour; Corina Kohler; Xiao Yan Zhong
Journal:  Obstet Gynecol Int       Date:  2010-07-27

7.  DNA hypermethylation of tumors from non-small cell lung cancer (NSCLC) patients is associated with gender and histologic type.

Authors:  Stephen E Hawes; Joshua E Stern; Qinghua Feng; Linda W Wiens; Janet S Rasey; Hiep Lu; Nancy B Kiviat; Hubert Vesselle
Journal:  Lung Cancer       Date:  2009-11-28       Impact factor: 5.705

8.  Locked nucleic acids can enhance the analytical performance of quantitative methylation-specific polymerase chain reaction.

Authors:  Karen S Gustafson
Journal:  J Mol Diagn       Date:  2007-12-28       Impact factor: 5.568

9.  Classification of individual lung cancer cell lines based on DNA methylation markers: use of linear discriminant analysis and artificial neural networks.

Authors:  Alberto M Marchevsky; Jeffrey A Tsou; Ite A Laird-Offringa
Journal:  J Mol Diagn       Date:  2004-02       Impact factor: 5.568

10.  Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation.

Authors:  Emanuela Taioli; Camille Ragin; Xiao-Hong Wang; Jiangying Chen; Scott M Langevin; Ashley R Brown; Susanne M Gollin; Seymour Garte; Robert W Sobol
Journal:  BMC Cancer       Date:  2009-10-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.